ABBOTT LABORATORIES Logo

ABBOTT LABORATORIES

Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.

ABT | US

Overview

Corporate Details

ISIN(s):
US0028241000
LEI:
Country:
United States of America
Address:
100 ABBOTT PARK ROAD, ABBOTT PARK

Description

Abbott Laboratories is a global healthcare company that discovers, develops, manufactures, and sells a broad portfolio of life-changing technologies. The company's operations are focused on four core businesses: Medical Devices, Diagnostics, Nutrition, and Established Pharmaceuticals. The Medical Devices division offers solutions for cardiovascular health, diabetes care (including the FreeStyle Libre continuous glucose monitoring system), and neuromodulation. The Diagnostics segment provides a wide range of in vitro diagnostic systems and tests for hospitals, laboratories, and clinics. The Nutrition business develops and markets science-based nutritional products for people of all ages, with leading brands such as Similac, PediaSure, Ensure, and Glucerna. The Established Pharmaceuticals division provides a portfolio of branded generic medicines to consumers in emerging markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-25 22:17 English 9.8 KB
2025-11-25 22:08 English 9.7 KB
2025-11-21 22:06
FORM 8-K
English 88.0 KB
2025-11-20 13:37
FORM 8-K
English 4.6 MB
2025-10-29 21:22
10-Q
English 1.5 MB
2025-10-15 13:33
8-K
English 190.7 KB
2025-10-02 23:02 English 7.2 KB
2025-10-02 22:50 English 6.9 KB
2025-10-02 22:42 English 7.1 KB
2025-10-02 22:34 English 7.2 KB
2025-09-03 23:39 English 9.7 KB
2025-09-03 23:31 English 6.6 KB
2025-08-11 23:53 English 10.0 KB
2025-08-09 00:30 English 6.7 KB
2025-07-30 22:14
10-Q
English 1.5 MB

Automate Your Workflow. Get a real-time feed of all ABBOTT LABORATORIES filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ABBOTT LABORATORIES

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ABBOTT LABORATORIES via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Adaptimmune Therapeutics PLC Logo
Commercial-stage biopharma developing TCR T-cell therapies for solid tumors.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops IgY-based immune antibodies as alternatives to vaccines and antibiotics.
South Korea
179530
ADC Therapeutics SA Logo
Commercial-stage biotech developing antibody-drug conjugates for cancer therapy.
United States of America
ADCT
Addex Therapeutics Ltd. Logo
Clinical-stage biopharma developing allosteric modulators for neurological disorders.
Switzerland
ADXN
ADIAL PHARMACEUTICALS, INC. Logo
A clinical-stage biopharma developing genetically targeted therapies for addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Develops allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET
Adlai Nortye Ltd. Logo
A clinical-stage biopharma firm developing cancer immunotherapies and RAS-targeting drugs.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
Biopharmaceutical company that develops and manufactures plasma-derived biologics.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
A clinical-stage company developing gene therapies for ocular diseases.
United States of America
ADVM
Advicenne Logo
A specialty pharmaceutical company developing treatments for rare renal diseases.
France
ALDVI

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.